baber/WOPTO huggingface dataset:
Patent CY-1118522-T1 (CY)
Title: Σταθερα μορφοποιημενα σωματιδια κρυσταλλικων οργανικων ενωσεων
Inventor: URIBE JUAN ANGELES
IPC: A61K9/16
Filed: 2016-12-28
Abstract: Η παρούσα εφεύρεση παρέχει σταθερά κατά την αποθήκευση, μορφοποιημένα σωματίδια αλλοτροπικών οργανικών ενώσεων. Τα σωματίδια της παρούσας εφεύρεσης μπορεί να μορφοποιηθούν ανάλογα με την επιθυμητή εφαρμογή. Προτιμητέα σχήματα τέτοιων σωματιδίων είναι οι μικροσφαίρες, ειδικότερα εκείνες οι οποίες έχουν διαμέτρους από περίπου 1 έως περίπου 1000 μικρόμετρα. Τα σταθερά μορφοποιημένα σωματίδια της παρούσας εφεύρεσης είναι ιδιαίτερα καλά προσαρμοσμένα για την κατασκευή φαρμακευτικών σκευασμάτων, ειδικότερα όπου παρατεταμένη απελευθέρωση και ομοιόμορφη βιοδιαθεσιμότητα είναι επιθυμητές. Τα σταθερά κατά την αποθήκευση σωματίδια σχηματίζονται από μια στερεάς κατάστασης κρυστάλλωση αλλοτροπικών οργανικών ενώσεων. Η διαδικασία στερεάς κατάστασης κρυστάλλωσης της παρούσας εφεύρεσης παρέχει ένα μέσο για επίτευξη μιας σταθερής κατά την αποθήκευση κρυσταλλικής μορφής της εν λόγω αλλοτροπικής ένωσης χωρίς απώλεια ή φθορά των αρχικών διαστάσεων των σωματιδίων.
Patent CY-1119377-T1 (CY)
Title: Φαρμακευτικη συνθεση
Inventor: KOJIMA MASAZUMI
IPC: A61P9/10
Filed: 2017-09-20
Abstract: Παρέχεται φαρμακευτικό παρασκεύασμα που δεικνύει ικανοποιητική ιδιότητα διαλυτοποίησης σε μία ευρεία περιοχή pΗ. Η φαρμακευτική σύνθεση χαρακτηρίζεται από το ότι περιέχει (Α) Ν1-(5-χλωροπυριδιν-2-υλ)-Ν2-((1S,2R,4S)-4-[(διμεθυλαμινο) καρβονυλ]-2-{[(5-μεθυλ-4,5,6,7-τετραϋδροθειαζολο[5,4-c]πυριδιν-2-υλ)καρβονυλ] αμινο}κυκλοεξυλ)αιθανοδιαμίδιο, που αντιπροσωπεύεται με τον ακόλουθο τύπο (1), φαρμακολογικώς αποδεκτό άλας αυτού ή υδρίτη οιουδήποτε από αυτά και (Β) ένα ή περισσότερα είδη που επιλέγονται από την ομάδα που αποτελείται από σακχαρο-αλκοόλη και υδατο-διογκώσιμο πρόσθετο.
Patent CY-1119864-T1 (CY)
Title: Μεθοδος για την κωδικοποιηση βιντεο που μοιραζονται παραμετρο sao συμφωνα με το συστατικο χρωματος
Inventor: ALSHINA ELENA
IPC: H04N19/91
Filed: 2018-01-30
Abstract: Μέθοδος κωδικοποίησης βίντεο και συσκευή και μέθοδος αποκωδικοποίησης βίντεο και συσκευή για παραγωγή μιας ανακατασκευασμένης εικόνας που έχει ένα ελαχιστοποιημένο σφάλμα ανάμεσα σε μια αρχική εικόνα και την ανακατασκευασμένη εικόνα. Η μέθοδος αποκωδικοποίησης βίντεο συνοδευόμενη από μια ρύθμιση προσαρμοστικής μετατόπισης δείγματος (SAO), η μέθοδος περιλαμβάνει: απόκτηση παραμέτρων SAO φέτας σύμφωνα με την τρέχουσα φέτα από την επικεφαλίδα φέτας ενός λαμβανόμενου συρμού δυαδικών ψηφίων, απόκτηση πληροφοριών χρήσης φωτεινότητας SAO για ένα συστατικό φωτεινότητας της τρέχουσας φέτας και πληροφοριών χρήσης χρώματος SAO για συστατικά χρώματος αυτής από μεταξύ των παραμέτρων SAO της φέτας, προσδιορισμό του εάν θα επιτελεστεί μια διαδικασία SAO στο συστατικό φωτεινότητας της τρέχουσας φέτας βάσει των αποκτηθέντων πληροφοριών χρήσης φωτεινότητας SAO και με τον ίδιο τρόπο προσδιορισμό του εάν θα επιτελεστεί η ρύθμιση SAO σε ένα πρώτο συστατικό χρώματος και σε ένα δεύτερο συστατικό χρώματος της τρέχουσας φέτας βάσει των αποκτηθέντων πληροφοριών χρήσης χρώματος SAO.
Patent CY-1125086-T1 (CY)
Title: Rna ρεπλικονιο για την ευελικτη και αποδοτικη εκφραση γονιδιου
Inventor: BEISSERT TIM
IPC: A61K35/76
Filed: 2022-01-26
Abstract: Η παρούσα εφεύρεση περιλαμβάνει ένα ρεπλικόνιο RNA, το οποίο μπορεί να αντιγραφεί από μια ρεπλικάση αλφαϊού προέλευσης. Το ρεπλικόνιο RNA περιλαμβάνει στοιχεία αλληλουχίας που απαιτούνται για την αντιγραφή από την ρεπλικάση. αλλά αυτά τα στοιχεία αλληλουχίας δεν κωδικοποιούν οποιαδήποτε πρωτεΐνη ή θραύσμα αυτής, όπως μια μη δομική πρωτεΐνη αλφαϊού ή ένα θραύσμα αυτής. Έτσι, στο ρεπλικόνιο RNA σύμφωνα με την εφεύρεση, τα στοιχεία αλληλουχίας που απαιτούνται για την αντιγραφή από την ρεπλικάση και την (-ις) περιοχή (-ές) κωδικοποίησης πρωτεΐνης είναι μη συνδεδεμένα. Σύμφωνα με την παρούσα εφεύρεση, η μη σύζευξη επιτυγχάνεται με την απομάκρυνση τουλάχιστον ενός κωδικονίου έναρξης σε σύγκριση με ένα γονιδιωματικό RNA φυσικού αλφαϊού. Συγκεκριμένα, το ρεπλικόνιο RNA περιλαμβάνει μια αλληλουχία αναγνώρισης αντιγραφής 5', όπου η αλληλουχία αναγνώρισης αντιγραφής 5' χαρακτηρίζεται από το ότι περιλαμβάνει την απομάκρυνση τουλάχιστον ενός κωδικονίου έναρξης σε σύγκριση με μια αλληλουχία αναγνώρισης αντιγραφής 5' φυσικού αλφαϊού. Η ρεπλικάση προέλευσης αλφαϊού μπορεί να κωδικοποιηθεί από ένα ανοικτό πλαίσιο ανάγνωσης στο ρεπλικόνιο RNA ή σε ένα ξεχωριστό μόριο RNA. Η παρούσα εφεύρεση καθιστά δυνατή την αποτελεσματική και την ασφαλή έκφραση μιας πρωτεΐνης ενδιαφέροντος σε ένα κύτταρο ή οργανισμό, αλλά δεν συνδέεται με μια ανεπιθύμητη παραγωγή θραυσμάτων μη δομικής πρωτεΐνης αλφαϊού. Μέθοδοι παραγωγής πρωτεΐνης in vitro και in vivo, καθώς και ιατρικές χρήσεις, παρέχονται στο παρόν.
Patent SI-1516715-T1 (SI)
Title: Manufacturing method of an orthotic and orthotic made by such a method
Inventor: KATZER ROLAND
IPC: A61F5/00
Filed: 2003-09-17
Abstract: A heated and softened plastic skin or plate(4) is pressed(3) at the edge of the insert sole using a compression-injection tool and the plastic is forced partly into the tool cavity. A supporting part(5) is then injection molded in the remaining space in the tool and together with the plastic skin or plate forms a composite shoe insert(2). A heated and softened plastic skin or plate(4) is pressed(3) at the edge of the insert sole using a compression-injection tool and the plastic is forced partly into the tool cavity. A supporting part(5) is then injection molded in the remaining space in the tool and together with the plastic skin or plate forms a composite shoe insert(2). The injected material of the supporting part is harder than the plastic skin or plate material. Softening of the plastic is by use of a radiant heater, an oven and/or a heating plate. or the injection molding tool. A raised edge around the cavity of the compression-injection tool compresses the plastic skin or plate(4). is surrounded by raised edge. The edge outside the shoe insert remains uncompressed(9). During compression the shoe insert(2) is pressed in an edge area from 1-4mm, preferably 2-3mm down to a thickness of almost zero. Additional upper and/or lower material may be added to the shoe insert using heat activated adhesive. Injection of the supporting part may be effected via a film runner at the edge of the shoe sole close to the arch in the longitudinal direction. An independent claim is included for an orthopaedic shoe insert comprising a plastic skin or flexible plastic plate which is thinned around the outer periphery to a thickness of almost zero. A central area forming a supporting part(5) is produced by injection of a harder thermoplastic plastic onto the softer skin or plate.
Patent SI-1542658-T1 (SI)
Title: Pharmaceutical compositions comprising an opioid analgesic
Inventor: OSHLACK BENJAMIN
IPC: A61K9/50
Filed: 2003-08-15
Abstract: Pharmaceutical compositions containing a therapeutically active agent, a diffusion barrier coating and coating comprising a hydrophobic material.
Patent SI-1682121-T1 (SI)
Title: Use of crth2 antagonist compounds in therapy
Inventor: MIDDLEMISS DAVID
IPC: A61K31/00
Filed: 2004-10-19
Abstract: Compounds of general formula (I) wherein R 1 , R 2 , R 3  and R 4  are independently hydrogen, halo, C 1 -C 6  alkyl, -O(C 1 -C 6  alkyl), -CON(R 11 ) 2  , -SO 11 , -SO 2 R 11 , - SO 2 N(R 11 ) 2 , -N(R 11 ) 2 , -NR 11 COR 11 , -CO 2 R 11 , -COR 11 , -SR 11 , -OH, -NO 2  or -CN; each R 11  is independently hydrogen or C 1 -C 6  alkyl; R 5  and R 6  are each independently hydrogen, or C 1 -C 6  alkyl or together with the carbon atom to which they are attached form a C 3 -C 7  cycloalkyl group; R 7  is hydrogen or C 1 -C 6  alkyl; R 8  is an aromatic moiety optionally substituted with one or more substituents selected from halo, C 1 -C 6  alkyl, -O(C 1 -C 6 )alkyl, -CON(R 11 ) 2 , -SOR 11 , -SO 2 R 11 , -SO 2 N(R 11 ) 2 , -N(R 11 ) 2 , - NR 11 COR 11 , -CO 2 R 11 , -COR 11 , -SR 11 , -OH, -NO 2  or -CN; wherein R 11  is as defined above; R 9  is hydrogen, or C 1 -C 6  alkyl; provided that: R 8  is not phenyl substituted with -COOH; when any two of R 1 , R 2 , R 3  and R 4  are hydrogen, neither of the other two of R 1 , R 2 , R 3  and R 4  is C 3 -C 6  alkyl; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in the preparation of pharmaceuticals for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.
Patent SI-1751184-T1 (SI)
Title: Fgf-21 fusion proteins
Inventor: GLAESNER WOLFGANG
IPC: C12N15/00
Filed: 2005-05-02
Abstract: The invention provides specific FGF-21 compounds fused to specific IgG4-Fc or HSA derivatives resulting in fusion proteins that are biologically active with an extended elimination half-life and a slower clearance. These FGF-21 compound fusion proteins and compositions are useful in treating type 2 diabetes, obesity, and metabolic syndrome.
Patent SI-1825387-T1 (SI)
Title: System and method for disaster recovery and management of an email system
Inventor: PETTIGREW NANCY
IPC: G06F15/00
Filed: 2005-11-18
Abstract: The present invention provides an improved system and method for disaster recovery and management of an email system. The system includes a deferral monitor that detects when a failure occurs in a client's email system, and a mailbox creation process and automatically creates mailbox accounts for the affected domains that queue incoming mail while the failure is repaired. This ensures no email is bounced because of the unavailable mail servers. Once the email servers are reconnected, the system forwards queued email to the client in a "flow-controlled" manner until all email is delivered. The system may further include a web mail interface that allows the client to maintain email functionality until the failure is repaired. The system may also include a message switch that filters all email for policy and content rules, spam and viruses before passing the email to the client.
Patent SI-2058323-T1 (SI)
Title: Tumour-associated peptides which bind to MHC molecules
Inventor: TRAUTWEIN CLAUDIA
IPC: A61K38/00
Filed: 2005-05-24
Abstract: Tumor-associated peptide having a 9-17 residue amino acid sequence from the groups SEQ ID-No. 1-577 from a given sequence protocol. The peptide has the ability to bond with a molecule of the human class I major histocompatibility complex (MHC) proteins. At least one amino acid is chemically modified, or at least one amino acid is deleted, or at least one amino acid is replaced by another amino acid with similar chemical characteristics. Tumor-associated peptide having a 9-17 residue amino acid sequence from the groups SEQ ID-No. 1-577 from a given sequence protocol. The peptide has the ability to bond with a molecule of the human class I major histocompatibility complex (MHC) proteins. At least one amino acid is chemically modified, or at least one amino acid is deleted, or at least one amino acid is replaced by another amino acid with similar chemical characteristics. The N and/or C terminal is available of at least one other amino acid. ACTIVITY : Cytostatic. No biological data is given. MECHANISM OF ACTION : None given.
Patent SI-1765292-T1 (SI)
Title: Abuse-deterrent drug formulations
Inventor: HIRSH JANE
IPC: A61K9/00
Filed: 2005-06-10
Abstract: An abuse-deterrent pharmaceutical composition has been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opioids. In a preferred embodiment, a drug is modified to increase its lipophilicity. In some embodiments the modified drug is homogeneously dispersed within spherical microparticles composed of a material that is either slowly soluble or not soluble in water. In some embodiments the drug containing microparticles or drug particles are coated with one or more coating layers, where at least one coating is water insoluble and/or organic solvent insoluble. The abuse-deterrent composition retards the release of drug, even if the physical integrity of the formulation is compromised (for example, by chopping with a blade or crushing) and the resulting material is placed in water, snorted, or swallowed. However, when administered as directed, the drug is slowly released from the composition as the composition is passes through the GI tract.
Patent SI-1724397-T1 (SI)
Title: Method and device for measuring railway line parameters
Inventor: TAVERNA ENZO
IPC: E01B35/00
Filed: 2006-05-19
Abstract: It is provided a method for the measuring of a railway line parameters and a measuring device (10) therefor, the railway line comprising two or more rails (1) on a track level (PF), a plurality of supporting posts (2) for electrical contact wires (4) on a contact level (PC). The device is characterised in that it comprises an elongated main body (10), fastening means (11, 12, 13) of said main body onto said track (1), first telemetry means (14, 15), and second telemetry means (16).
Patent SI-2077012-T1 (SI)
Title: Method, system and computer program for exchanging messages in a mobile radio network
Inventor: ROBKE MATTHIAS
IPC: H04L12/58
Filed: 2007-09-26
Abstract: The invention relates to a method for exchanging messages in a mobile radio system by means of a convergent messaging system, which allows an exchange of messages between the terminals of two or more users. According to the invention, a message thread is detected by one of the terminals as soon as a terminal receives a response to a previously sent message, wherein the detection of a message thread by this terminal triggers a recording of the message exchange in the convergent messaging system.
Patent SI-2101429-T1 (SI)
Title: Method and apparatus for receiving control information in a wireless communication system
Inventor: KWON HWAN-JOON
IPC: H04L1/00
Filed: 2009-03-03
Abstract: A method and apparatus for transmitting/receiving control information in a wireless communication system are provided, in which physical layer signaling information to be transmitted in a frame is determined, at least one coded block is generated from signaling information having a variable number of bits included in the physical layer signaling information, and a frame including the at least one coded block is transmitted. The frame includes other signaling information having a fixed number of bits required for receiving the signaling information having the variable number of bits.
Patent SI-2410110-T1 (SI)
Title: Locking cylinder, in particular double locking cylinder with free-running locking element
Inventor: SCHMITT HERMANN-JOSEF
IPC: E05B27/00
Filed: 2011-07-07
Abstract: The cylinder has a cylinder core coupled with a locking unit (6) by coupling elements (7, 8) during pushing of a key into a key channel, where the coupling elements are moved to a coupling position by a key tip. A coupling projection (9) of the coupling elements engages in a coupling recess (11) of the locking unit in the position. The coupling elements are moved from the position when the key is pulled by applying torque on the locking unit. A controller controls torque transmission edges (10, 12) of the projection and/or the recess for moving the coupling elements from the position.
Patent SI-2694072-T1 (SI)
Title: Combination of akt inhibitor compound and abiraterone for use in therapeutic treatments
Inventor: NANNINI MICHELLE
IPC: C07D239/00
Filed: 2012-03-30
Abstract: The invention provides A combination of, a) a compound of Formula Ia: or a pharmaceutically acceptable salt thereof; and b) erlotinib or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer.
Patent TR-200602570-T1 (TR)
Title: Bir yıkayıcı/kurutucu
Inventor: KOESE METIN
IPC: D06F34/26
Filed: 2004-12-06
Abstract: Bu buluş, kazan çıkışına (11) yerleştirilen pervane (14) ile, kondenser (8) ve dolaşım kanalına (4)ulaşan lif ve hav miktarı azaltılan bir yıkayıcı/kurutucu (1) ile ilgilidir.
Patent TR-200708579-T1 (TR)
Title: Bir buzdolabı.
Inventor: CELIK RIDVAN KADIR
IPC: F25D31/00
Filed: 2006-06-23
Abstract: Bu buluş, içinde oluşturulan buzların istenilen yerde kullanılabilmesini sağlayan bir buzluk (4) içeren bir buzdolabı (1) ile ilgilidir.
Patent TR-201613810-T1 (TR)
Title: İletişim cihazı, iletişim sistemi ve iletişim usulü.
Inventor: TAKAYUKI SASAKI
IPC: G08C19/00
Filed: 2015-03-20
Abstract: Ağlardan birine bağlandığında, daha iyi bir iletişim kalitesine sahip başka bir ağ aramasına ve ağa katılmasına izin verilen bir iletişim cihazı sağlanmıştır; burada bir sayıcı değeri, bir sayaç okuma aygıtı (3-1) ağa (100A) bağlıyken, bir üçüncü iletişim devresinin (35) bir kaçak sinyali kaç kez aldığını belirtir; kaçak sinyal, başka ağa (100B veya 100C) bağlı ve birbirleriyle iletişim gerçekleştiren başka iletişim cihazlarından gelmektedir. Her zaman aralığında üçüncü iletişim devresi (35) kaçak sinyali alırsa bir sayaç okuma aygıtında bulunan kumanda devresi (31) sayıcı değerini arttırır. Bir zaman aralığında, eğer sayıcı değeri bir birinci eşik değerden daha büyük veya ona eşitse sayaç okuma aygıtında bulunan kumanda devresi (31) üçüncü iletişim devresinin (35) bir tarama talep sinyalini yayınlamasına neden olur.
Patent DE-3587048-T2 (DE)
Inventor: KISSEL THOMAS
IPC: A61P29/00
Filed: 1985-02-22
Granted: 1993-06-03
Abstract: The present invention provides a pharmaceutical composition for the transdermal systemic administration of a pharmacologically active agent characterised in that it contains tizanidine as active agent in a reservoir comprising a hydrophilic polymer.
Patent DE-3686518-T2 (DE)
Inventor: KRUMME JOHN F
IPC: H01R33/76
Filed: 1986-06-09
Granted: 1993-03-25
Abstract: A self-heating and self-soldering bus bar for use in many applications. The pins of the bus bar are quickly and directly heated to a predetermined autoregulated temperature without significantly raising the temperature of the body of the bus. Thusly a bus bar may be mounted while maintaining thermal balance and mechanical integrity of all wotk pieces. The present invention avoids the problems normally associated with excess thermal expansion experienced when a bus bar is heated incidental to the heating of its contact points. A majority of this incidental heating is eliminated by direct quick heating of the mounting pins.
Patent DE-3687246-T2 (DE)
Inventor: SOMA GEN-ICHIRO
IPC: A61K38/17
Filed: 1986-07-23
Granted: 1993-06-24
Abstract: This invention relates to a novel anti-tumor polypeptide prepared by suspended-culture of human acute monocytic leukemia cells THP-1 under or after contact with a differentiation inducing agent. The novel anti-tumor polypeptide do not exhibit cytotoxicity against human normal cells but give cytotoxicity to human tumor cells Hela, KB and T-24 cells which is known to be insensitive to conventional TNF, and mouse tumor cells such as sarcoma 180 and L-1210. The antitumor polypeptides may be prepared by a non-expensive serum-free medium.
Patent DE-3687455-T2 (DE)
Inventor: BROSH AMNON
IPC: G01D5/22
Filed: 1986-08-29
Granted: 1993-07-08
Abstract: There is disclosed a digital enhancement circuit which responds to the complementary inductance provided by a planar coil sensor (L1, L2) which inductance varies in a complementary manner according to the position of a movable member associated with the planar coil configuration (L1, L2). The complementary inductance is coupled to an oscillator (30) whereby the period of the oscillator (30) is varied in a first mode according to a first inductance value and in a second mode according to a second inductance value. These signals are then processed by means of digital processing circuitry to develop a signal indicative of the difference of the periods as divided by the sum of the periods. This signal is a ratiometric signal, and by employing digital counters, one can provide an output signal having a predetermined gain factor and having the above noted ratiometric characteristic which signal is indicative of the position of the movable member as further enhanced by the gain factor.
Patent DE-3781584-T2 (DE)
Inventor: SOSIN BOLESLAW MARIAN
IPC: H03F1/32
Filed: 1987-04-10
Granted: 1993-01-07
Abstract: A robust amplifier consists of two delay lines 12 and 23 linked by a number of discrete amplifiers 13. Distortion correction is carried out by distortion feed forward. This is achieved by sampling the output of each amplifier 13 at a coupler 17 and then subtracting this sample from the input signal to later amplifiers (13) along the delay line 12 at directional coupler 19. As a result each discrete amplifier's distortion is corrected by all of the following discrete amplifiers (13) in the amplifying circuit.
Patent DE-3789212-T2 (DE)
Inventor: MAYDAN DAN
IPC: H01L21/00
Filed: 1987-12-18
Granted: 1994-06-01
Abstract: An integrated modular multiple chamber vacuum processing system (10) is disclosed. The system includes a load lock (12), may include an external cassette elevator (24), and an internal load lock wafer elevator (50), and also includes stations about the periphery of the load lock for connecting one, two or several vacuum process chambers (16 to 22) to the load lock chamber (12). A robot (80) is mounted within the load lock and utilizes a concentric shaft drive system (82) connected to an end effector via a dual four-bar link mechanism (86) for imparting selected R-0 movement to the blade (84) to load and unload wafers at the external elevator, internal elevator and individual process chambers (16-22). The system is uniquely adapted for enabling various types of IC processing including etch, deposition, sputtering and rapid thermal annealing chambers, thereby providing the opportunity for multiple step, sequential processing using different processes.
Patent DE-3852086-T2 (DE)
Inventor: COY DAVID H
IPC: A61P31/04
Filed: 1988-09-26
Granted: 1995-05-18
Abstract: A linear peptide which is an analog of a naturally occurring, biologically active bombesin having an active site and a binding site responsible for binding of bombesin to a receptor on a target cell, cleavage of a peptide bond in the active site of the naturally occurring peptide being unnecessary for in vivo biological activity, the analog having a non-peptide bond instead of a peptide bond between an amino acid of the active site and an adjacent amino acid, and having the same binding site as the naturally occurring peptide, so that the analog, is capable of acting as a competitive inhibitor of naturally occurring bombesin by binding to the receptor and, by virtue of the non-peptide bond, failing to exhibit the in vivo activity of naturally occurring bombesin.
Patent DE-3855504-T2 (DE)
Inventor: HELDIN CARL-HENRIK
IPC: C12N1/16
Filed: 1988-04-22
Granted: 1997-01-23
Abstract: DNA encoding two forms of PDGF A-chain polypeptide, the construction of expression vectors for expressing such DNA in yeast and mammalian cells, and the expression of such DNA in yeast and mammalian cells to produce active PDGF A-chain homodimer and active PDGF A-chain/B-chain heterodimer are disclosed.
Patent DE-3873932-T2 (DE)
Inventor: PATRY JEAN
IPC: F25D3/00
Filed: 1988-01-06
Granted: 1993-07-22
Abstract: A recipient which is filled with a storage medium which expands during phase transformation wherein the recipient is a flexible structure having a geometrical shape such that only the flexibility of the structure is required to increase its volume to compensate for the expansion of the stored medium without creating stress or stretching the walls of the structure.
Patent TR-199802284-T2 (TR)
Inventor: JOHNS DR AMANDA
IPC: C07D401/12
Filed: 1997-05-06
Abstract: Bu bulus yeni tetrahidroizokuinolin türevleri, bunlarin preparasyon prosesleri, onlari içeren farmasötik kompozisyonlar ve onlarin özellikle antipsikotik maddeler olarak dopamin D3 reseptör modülatörleri olarak terapide kullanimlari ile ilgilidir.